KRAS and pancreatic neoplasm: As shown in Figure 7, A–C, anti–human programmed death 1 (anti–PD-1) antibody did not enhance the reactivity of TCR-001–transduced allogeneic T cells to human pancreatic cancer organoids with natural KRAS G12V mutation and HLA-A*11:01 expression, which might be due to low-level PD-1 expression of TCR-001–transduced allogeneic T cells (data not shown).